Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The ethics of placebo controlled clinical trials in NMO - A balance of risks.
Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis.
Erratum.
During Infection Theiler's Virions are Cleaved by Caspases and Disassembled into Pentamers.
Bone mineral density and body composition in men with multiple sclerosis chronically treated with low-dose glucocorticoids.
Lymphomatosis cerebri Presenting as a Recurrent Leukoencephalopathy.
Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study.
Anti-IL-17A Treatment Reduces Clinical Score and VCAM-1 Expression Detected by in Vivo Magnetic Resonance Imaging in CR-EAE ABH Mice.
Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis.
Differentiating patterns of oligoclonal banding in the cerebrospinal fluid and the diagnosis of multiple sclerosis.
Combining Self-help and Professional Help to Minimize Barriers to Physical Activity in Persons With Multiple Sclerosis: A Trial of the "Blue Prescription" Approach in New Zealand.
Natalizumab therapy for multiple sclerosis.
Inter- and intra-laboratory comparison of JC polyomavirus antibody testing using two different virus-like particle (VLP)-based assays.
[Current therapy of multiple sclerosis].
Unraveling the neuroimaging predictors for motor dysfunction in long-standing multiple sclerosis.
Mesenchymal stem cells: A new diagnostic tool?
Electrolyte imbalance triggering relapse of inflammatory neuropathy.
Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol.
Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain), 2008-2012.
Gait kinematics of people with Multiple Sclerosis and the acute application of Functional Electrical Stimulation.
Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression.
Rehabilitation interventions for the management of multiple sclerosis relapse: a short scoping review.
Pathophysiological processes in multiple sclerosis: focus on nuclear factor erythroid-2-related factor 2 and emerging pathways.
Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study.
Oligodendrogenesis in the normal and pathological central nervous system.

Pages